Facebook Linkedin RSS Twitter Youtube
Home 2024

Clostridium difficile

Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML
Artificial Intelligence

Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML

Antibiotic Slays Gram-Negative Bacteria, Spares Commensals in Mice
Drug Discovery

Antibiotic Slays Gram-Negative Bacteria, Spares Commensals in Mice

Drugs, Dollars, and Data: Recursion Eyes Cost Savings from AI Drug Discovery
Artificial Intelligence

Drugs, Dollars, and Data: Recursion Eyes Cost Savings from AI Drug Discovery

Colonic Organoids Generate Functional Resident Macrophages
News

Colonic Organoids Generate Functional Resident Macrophages

Ferrosomes Discovered in C. difficile Offer Novel Therapeutic Target
Infectious Diseases

Ferrosomes Discovered in C. difficile Offer Novel Therapeutic Target

NSAIDs Sensitize Colon Cells to C. diff Toxin, Disrupting Mitochondria
Featured

NSAIDs Sensitize Colon Cells to C. diff Toxin, Disrupting Mitochondria

C. Diff Colonization Halted by Gut Enzymes
News

C. Diff Colonization Halted by Gut Enzymes

Reporter’s Notebook: On Day 2 of J.P. Morgan, Start-Ups Soliciting Cash and VCs Eschewing High Risk
GEN Edge

Reporter’s Notebook: On Day 2 of J.P. Morgan, Start-Ups Soliciting Cash and VCs Eschewing High Risk

Intestinal C. Difficile Infection Supported by Antibiotic-Resistant Gut Bacteria
News

Intestinal C. Difficile Infection Supported by Antibiotic-Resistant Gut Bacteria

Bacterial Enzyme Could Become a New Target for Antibiotics
Drug Discovery

Bacterial Enzyme Could Become a New Target for Antibiotics

1234Page 1 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.